Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Lasers in Medical Science
Published in: Lasers in Medical Science 7/2017

01-09-2017 | Original Article

Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer

Authors: Nazila Eyvazzadeh, Ali Shakeri-Zadeh, Reza Fekrazad, Elahe Amini, Habib Ghaznavi, S. Kamran Kamrava

Published in: Lasers in Medical Science | Issue 7/2017

Login to get access

Abstract

Because of their great scientific and technological potentials, iron oxide nanoparticles (IONPs) have been the focus of extensive investigations in biomedicine over the past decade. Additionally, the surface plasmon resonance effect of gold nanoparticles (AuNPs) makes them a good candidate for photothermal therapy applications. The unique properties of both IONPs (magnetic) and AuNPs (surface plasmon resonance) may lead to the development of a multi-modal nanoplatform to be used as a magnetic resonance imaging (MRI) contrast agent and as a nanoheater for photothermal therapy. Herein, core–shell gold-coated IONPs (Au@IONPs) were synthesized and investigated as an MRI contrast agent and as a light-responsive agent for cancer photothermal therapy.
The synthesized Au@IONPs were characterized by UV–visible spectroscopy, transmission electron microscopy (TEM), dynamic light scattering (DLS), and zeta potential analysis. The transverse relaxivity (r 2) of the Au@IONPs was measured using a 3-T clinical MRI scanner. Through a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, the cytotoxicity of the Au@IONs was examined on a KB cell line, derived from the epidermal carcinoma of a human mouth. Moreover, the photothermal effects of Au@IONPs in the presence of a laser beam (λ = 808 nm; 6.3 W/cm2; 5 min) were studied.
The results show that the Au@IONPs are spherical with a hydrodynamic size of 33 nm. A transverse relaxivity of 95 mM−1 S−1 was measured for the synthesized Au@IONPs. It is evident from the MTT results that no significant cytotoxicity in KB cells occurs with Au@IONPs. Additionally, no significant cell damage induced by the laser is observed. Following the photothermal treatment using Au@IONPs, approximately 70% cell death is achieved. It is found that cell lethality depended strongly on incubation period and the Au@IONP concentration.
The data highlight the potential of Au@IONPs as a dual-function MRI contrast agent and photosensitizer for cancer photothermal therapy.
Literature
1.
Shakeri-Zadeh A, Mansoori GA, Hashemian AR, Eshghi H, Sazgarnia A, Montazerabadi AR (2010) Cancerous cells targeting and destruction using folate conjugated gold nanoparticles. Dyn Biochem Process Biotechnol Mol Biol 4(1):06–12
2.
Sazgarnia A, Montazerabadi AR, Bahreyni-Toosi MH, Ahmadi A (2013) Photosensitizing and radiosensitizing effects of mitoxantrone: combined chemo-, photo-, and radiotherapy of DFW human melanoma cells. Lasers Med Sci 28(6):1533–1539CrossRefPubMed
3.
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751–760CrossRefPubMed
4.
Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5(3):161–171CrossRefPubMed
5.
Beik J, Abed Z, Shakeri-Zadeh A, Nourbakhsh M, Shiran MB (2016) Evaluation of the sonosensitizing properties of nano-graphene oxide in comparison with iron oxide and gold nanoparticles. Physica E: Low-dimensional Systems and Nanostructures 81:308–314CrossRef
6.
Khoei S, Mahdavi SR, Fakhimikabir H, Shakeri-Zadeh A, Hashemian A (2014) The role of iron oxide nanoparticles in the radiosensitization of human prostate carcinoma cell line DU145 at megavoltage radiation energies. Int J Radiat Biol 90(5):351–356CrossRefPubMed
7.
Mansoori GA, Brandenburg KS, Shakeri-Zadeh A (2010) A comparative study of two folate-conjugated gold nanoparticles for cancer nanotechnology applications. Cancers 2(4):1911–1928CrossRefPubMedPubMedCentral
8.
Beik J, Abed Z, Ghadimi-Daresajini A, Nourbakhsh M, Shakeri-Zadeh A, Ghasemi MS et al (2016) Measurements of nanoparticle-enhanced heating from 1MHz ultrasound in solution and in mice bearing CT26 colon tumors. J Therm Biol 62:84–89CrossRefPubMed
9.
Shakeri-Zadeh A, Khoee S, Shiran M-B, Sharifi AM, Khoei S (2015) Synergistic effects of magnetic drug targeting using a newly developed nanocapsule and tumor irradiation by ultrasound on CT26 tumors in BALB/c mice. J Mater Chem B 3(9):1879–1887CrossRef
10.
Shakeri-Zadeh A, Khoei S, Khoee S, Sharifi AM, Shiran M-B (2015) Combination of ultrasound and newly synthesized magnetic nanocapsules affects the temperature profile of CT26 tumors in BALB/c mice. Journal of Medical Ultrasonics 42(1):9–16CrossRefPubMed
11.
Shakeri-Zadeh A, Shiran M-B, Khoee S, Sharifi AM, Ghaznavi H, Khoei S (2014) A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model. J Biomater Appl 29(4):548–556CrossRefPubMed
12.
Montazerabadi AR, Oghabian MA, Irajirad R, Muhammadnejad S, Ahmadvand D, Delavari HH et al (2015) Development of gold-coated magnetic nanoparticles as a potential MRI contrast agent. Nano 10(04):1550048CrossRef
13.
Chouly C, Pouliquen D, Lucet I, Jeune J, Jallet P (1996) Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J Microencapsul 13(3):245–255CrossRefPubMed
14.
Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021CrossRefPubMed
15.
Mehdizadeh A, Pandesh S, Shakeri-Zadeh A, Kamrava SK, Habib-Agahi M, Farhadi M et al (2014) The effects of folate-conjugated gold nanorods in combination with plasmonic photothermal therapy on mouth epidermal carcinoma cells. Lasers Med Sci 29(3):939–948CrossRefPubMed
16.
Shakeri-Zadeh A, Kamrava SK, Farhadi M, Hajikarimi Z, Maleki S, Ahmadi A (2014) A scientific paradigm for targeted nanophotothermolysis; the potential for nanosurgery of cancer. Lasers Med Sci 29(2):847–853CrossRefPubMed
17.
Aioub M, El-Sayed MA (2016) A real-time surface enhanced Raman spectroscopy study of plasmonic photothermal cell death using targeted gold nanoparticles. J Am Chem Soc 138(4):1258–1264
18.
Huang X, El-Sayed MA (2011) Plasmonic photo-thermal therapy (PPTT). Alexandria Journal of Medicine 47(1):1–9CrossRef
19.
Huang X, Jain PK, El-Sayed IH, El-Sayed MA (2008) Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 23(3):217CrossRefPubMed
20.
Hoshyar N, Gray S, Han H, Bao G (2016) The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine 11(6):673–692CrossRefPubMedPubMedCentral
21.
Liu Y, Yang M, Zhang J, Zhi X, Li C, Zhang C et al (2016) Human induced pluripotent stem cells for tumor targeted delivery of gold nanorods and enhanced photothermal therapy. ACS Nano 10(2):2375–2385
22.
Sood A, Arora V, Shah J, Kotnala R, Jain TK (2016) Ascorbic acid-mediated synthesis and characterisation of iron oxide/gold core–shell nanoparticles. J Exp Nanosci 11(5):370–382CrossRef
23.
Massart R (1981) Preparation of aqueous magnetic liquids in alkaline and acidic media. Magnetics, IEEE Transactions on 17(2):1247–1248CrossRef
24.
Jana NR, Gearheart L, Murphy CJ (2001) Seeding growth for size control of 5–40 nm diameter gold nanoparticles. Langmuir 17(22):6782–6786CrossRef
25.
Bagalkot V, Farokhzad OC, Langer R, Jon S (2006) An aptamer–doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed 45(48):8149–8152CrossRef
26.
Cheng G, Walker ARH (2007) Synthesis and characterization of cobalt/gold bimetallic nanoparticles. J Magn Magn Mater 311(1):31–35CrossRef
27.
Beik J, Abed Z, Ghoreishi FS, Hosseini-Nami S, Mehrzadi S, Shakeri-Zadeh A et al (2016) Nanotechnology in hyperthermia cancer therapy: from fundamental principles to advanced applications. J Control Release 235:205–221CrossRefPubMed
28.
Guo Y, Zhang Z, Kim D-H, Li W, Nicolai J, Procissi D et al (2013) Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles. Int J Nanomedicine 8:3437CrossRefPubMedPubMedCentral
29.
Khafaji M, Vossoughi M, Hormozi-Nezhad MR, Dinarvand R, Börrnert F, Irajizad A (2016) A new bifunctional hybrid nanostructure as an active platform for photothermal therapy and MR imaging. Sci Rep 6
30.
von Maltzahn G, Park J-H, Agrawal A, Bandaru NK, Das SK, Sailor MJ et al (2009) Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 69(9):3892–900
31.
Melancon MP, Elliott A, Ji X, Shetty A, Yang Z, Tian M et al (2011) Theranostics with multifunctional magnetic gold nanoshells: photothermal therapy and T2* magnetic resonance imaging. Investig Radiol 46(2):132CrossRef
32.
de Senneville BD, Roujol S, Jaïs P, Moonen CT, Herigault G, Quesson B (2012) Feasibility of fast MR-thermometry during cardiac radiofrequency ablation. NMR Biomed 25(4):556–562CrossRefPubMed
33.
Ma LL, Feldman MD, Tam JM, Paranjape AS, Cheruku KK, Larson TA et al (2009) Small multifunctional nanoclusters (nanoroses) for targeted cellular imaging and therapy. ACS Nano 3(9):2686–2696CrossRefPubMedPubMedCentral
34.
Samadian H, Hosseini-Nami S, Kamrava SK, Ghaznavi H, Shakeri-Zadeh A (2016) Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy. J Cancer Res Clin Oncol 142(11):2217–2229
35.
Vogl TJ, Mack MG, Müller P, Phillip C, Böttcher H, Roggan A et al (1995) Recurrent nasopharyngeal tumors: preliminary clinical results with interventional MR imaging-controlled laser-induced thermotherapy. Radiology 196(3):725–733CrossRefPubMed
36.
Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO et al (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61(4):250–281CrossRefPubMedPubMedCentral
37.
Wildeman MA, Nyst HJ, Karakullukcu B, Tan BI (2009) Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer. Head & neck oncology 1(1):40CrossRef
38.
Goudarzi S, Ahmadi A, Farhadi M, Kamrava SK, Mobarrez F, Omidfar K (2015) A new gold nanoparticle based rapid immunochromatographic assay for screening EBV-VCA specific IgA in nasopharyngeal carcinomas. J Appl Biomed 13(2):123–129CrossRef
Metadata
Title
Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer
Authors
Nazila Eyvazzadeh
Ali Shakeri-Zadeh
Reza Fekrazad
Elahe Amini
Habib Ghaznavi
S. Kamran Kamrava
Publication date
01-09-2017
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 7/2017
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-017-2267-x

Other articles of this Issue 7/2017

Lasers in Medical Science 7/2017 Go to the issue

Original Article

Fractional Er:YAG laser assisting topical betamethasone solution in combination with NB-UVB for resistant non-segmental vitiligo

Original Article

Laser irradiation promotes the proliferation of mouse pre-osteoblast cell line MC3T3-E1 through hedgehog signaling pathway

Original Article

Application of phototherapy for the healing of the navels of neonatal dairy calves

Original Article

In vitro studies to evaluate the effect of varying culture conditions and IPL fluencies on tenocyte activities

Original Article

Effects of PBM in different energy densities and irradiance on maintaining cell viability and proliferation of pulp fibroblasts from human primary teeth

Original Article

A review study to evaluate holmium:YAG laser lithotripsy with flexible ureteroscopy in patients on ongoing oral anticoagulant therapy